Due Diligence

Cassava Sciences (SAVA) 综合股票分析

前言优于其竞争对手，而且是在美国试验中唯一显示 ADAS-Cog 认知改善的药物。这份研究报告探讨了为什么这些数据的价值超过 1000 亿美元。市场如何评价 SAVA 竞争对手的劣质数据？下面的条形图以红色表示 SAVA 目前的估...

Hilary Metz Esq., talks about her father's improvement on Simufilam

Interview with Hilary Metz (video link) In introducing herself: Metz: My father started having symptoms, I’d say in 2019 that were just...

My Nan passed away today after battling dementia for 16 years

I wrote a poem about my Nan and my Grandad who fought by her side. by Revolution For more stories from Alzheimer's Disease families,...

Brief SAVA Investment Thesis

A helpful part of being long SAVA is that the outcome is not dependent on current share price, or sentiment. It's just approval of the...

1,433 views1 comment

Citizen's Petition to FDA for Expedited Approval of Simufilam

Artist William Utermohlen was diagnosed with AD (Alzheimer's disease) in 1995. In the figure above, he painted what he saw in the mirror....

How to enroll your family member in SAVA simufilam trial

There are 3 different simufilam trials going on right now. The two Phase 3 trials are actively recruiting. They are run by Premier...

Opinion: SAVA May be a Once in a Lifetime Opportunity

This is not investment advice, just the opinion and personal due diligence of the author. Do your own due diligence and consult with a...